Major stock indexes closed higher/lower on Friday, after the week saw a flurry of events including DeepSeek scare and ...
Daily Caller on MSN3d
Senate Committees Waging War On RFK Jr.’s MAHA Vision Are Knee Deep In Big Pharma, Food Industry CashSenators aiming critical questions at Kennedy this week found their contributions from the health care industry and their ...
The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
Hosted on MSN4d
Goldman Sachs Downgrades Moderna (MRNA)Fintel reports that on January 29, 2025, Goldman Sachs downgraded their outlook for Moderna (NasdaqGS:MRNA) from Buy to ...
Learn more about whether Natera, Inc. or Vertex Pharmaceuticals Incorporated is a better investment based on AAII's A+ ...
Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...
Shares of vaccine maker Moderna Inc. fell Wednesday as Goldman Sachs lowered its rating after the biotech's second cut to product revenue guidance in six months. Moderna shares (MRNA) fell 2% in ...
Moderna (MRNA) stock falls as Goldman Sachs downgrades the COVID-19 vaccine maker to Neutral from Buy, citing a lack of ...
J.P. Morgan analyst Jessica Fye maintained a Buy rating on Ascendis Pharma (ASND – Research Report) today and set a price target of $167.00.
The company says preclinical trials demonstrate its signature molecule can help prevent cell damage that can lead to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback